1. Home
  2. COSM vs PRPO Comparison

COSM vs PRPO Comparison

Compare COSM & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

N/A

Current Price

$0.22

Market Cap

33.8M

Sector

Health Care

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$23.65

Market Cap

38.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
COSM
PRPO
Founded
2009
N/A
Country
Greece
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
38.3M
IPO Year
2009
2000

Fundamental Metrics

Financial Performance
Metric
COSM
PRPO
Price
$0.22
$23.65
Analyst Decision
Analyst Count
0
0
Target Price
★ $2.95
N/A
AVG Volume (30 Days)
★ 2.2M
28.5K
Earning Date
11-24-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
46.15
★ 92.15
EPS
★ N/A
N/A
Revenue
★ $65,271,815.00
$24,049,000.00
Revenue This Year
$30.85
$233.72
Revenue Next Year
$51.74
$22.61
P/E Ratio
N/A
★ N/A
Revenue Growth
19.93
★ 29.77
52 Week Low
$0.16
$17.79
52 Week High
$0.77
$33.63

Technical Indicators

Market Signals
Indicator
COSM
PRPO
Relative Strength Index (RSI) 37.39 63.48
Support Level $0.17 $24.09
Resistance Level $0.28 $24.78
Average True Range (ATR) 0.04 1.42
MACD -0.01 0.72
Stochastic Oscillator 19.71 98.77

Price Performance

Historical Comparison
COSM
PRPO

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: